Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Feasibility Study on the FARAVIEW Technology

← catalyst calendar

NCT06175234

Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Na · None · Treatment
Enrollment
50actual
Sites
3
Countries
Czechia, Ireland, Spain

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-04-03actualWhen the study began enrolling
Primary completion2025-05-15actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-06-06actualThe whole study's end, after follow-up
First posted2023-12-18actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-09-17actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation

Intervention

  • Device: Ablation Treatment

Primary outcomes

what the primary-completion date above is the date OF
Number of subjects with PVI success
measured At the end of the ablation procedure
Number of subjects with PWI success
measured At the end of the ablation procedure
Physician feedback on FARAVIEW technology of the RHYTHMIA mapping system by means of a questionnaire
measured At the end of the ablation procedure
umber of subjects presenting with PV or PW reconnections site's standard of care method. Procedural complications: device and/or procedure-related AEs.
measured At the end of the ablation procedure

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed